Targeting macrophages in liver fibrosis

Lydia González del Barrio, David H. Ipsen, Dominik R. Pfister, Dora Hancz, Charlotte L. Scott · 2026

Read Targeting macrophages in liver fibrosis by Lydia González del Barrio, David H. Ipsen, Dominik R. Pfister, Dora Hancz, Charlotte L. Scott (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13236518.txt.

Description

Lydia González del Barrio and co-authors reviewed in 2026 immune cells called macrophages as targets for treating liver scarring. Fibrosis follows chronic liver injury and can end in organ failure. Macrophages sit at the centre of the scarred liver's environment, steering inflammation and repair. New research shows these cells take many more states than the classic two-type scheme suggested.

Liver scarring can reverse, and reversal tracks closely with macrophages shifting into restorative modes. Restorative cells clear dead material efficiently, quiet inflammatory signals, and break down scar matrix actively. Therapy design is moving away from simply blocking new immune cell arrivals toward reprogramming cells already in the liver. Cell-based treatments, where prepared macrophages are given to patients, are the newest direction discussed. The review maps opportunities and obstacles for each strategy in development.

Catalog record

CREATORLydia González del Barrio, David H. Ipsen, Dominik R. Pfister, Dora Hancz, Charlotte L. Scott
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13236518

Browse the full library · About the Tower of Babel